Day: August 5, 2024

Aura Minerals Inc. Announces Organizational Changes

ROAD TOWN, British Virgin Islands, Aug. 05, 2024 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) (“Aura” or the “Company”), announces recent changes in its leadership and management structure to the market. These changes reflect the Company’s ongoing commitment to optimizing operations and strengthening its leadership team to achieve strategic objectives. The appointments bring highly qualified and experienced professionals to key positions, ensuring a smooth transition and business continuity. Pitágoras Costa, current Corporate Project Manager, assumes the new position of Director of Projects and Construction, also in Corporate. Pitágoras has extensive experience in project management, development, and implementation, having led studies and project implementations at companies such as Yamana...

Continue reading

YY Group Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

SINGAPORE, Aug. 05, 2024 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”, “YYGH”, or the “Company”), a data and technology-driven provider of hotel and hospitality staffing and commercial cleaning and janitorial services, today announces that it has received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Capital Market (“Nasdaq”) on August 1, 2024, notifying the Company that it was not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon the receipt of a deficiency notification. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of...

Continue reading

Adams Diversified Equity Fund Announces Final Tender Offer Results

BALTIMORE, Aug. 05, 2024 (GLOBE NEWSWIRE) — Adams Diversified Equity Fund, Inc. (NYSE: ADX) announced today the final results of its offer to purchase up to 12,405,174 of its common shares at $22.47, 98% of the $22.93 net asset value per share (“NAV”) at the close of regular trading on the New York Stock Exchange on August 2, 2024, the expiration date (“Offer”), which include an updated proration factor. No other information about the Offer results has changed. Based on the final count by Equiniti Trust Company, LLC (“EQ”), the depositary for the tender offer, a total of 41,882,825 common shares of ADX were validly tendered and not withdrawn. The total amount of shares tendered exceeded the Offer amount, and the Fund will purchase tendered shares on a pro rata basis, disregarding fractions. The proration factor for shares purchased...

Continue reading

CVG Reports Second Quarter 2024 Results

EPS of $(0.05), Adjusted EPS of $0.06, reflecting additional restructuring activity Adjusted EBITDA of $10.0 million, free cash flow of $6.4 million Strategic actions taken to strengthen Vehicle Solutions Business Provides updated guidance for full year 2024 NEW ALBANY, Ohio, Aug. 05, 2024 (GLOBE NEWSWIRE) — CVG (NASDAQ: CVGI), a diversified industrial products and services company, today announced financial results for its second quarter ended June 30, 2024. Second Quarter 2024 Highlights (Compared with prior year, where comparisons are noted) Revenues of $229.9 million, down 12.3%, due primarily to a global softening in customer demand. Operating income of $0.8 million, down 95.2%; adjusted operating income of $5.7 million, down 65.9%. The decrease in operating income was driven primarily by lower sales volumes, partially offset...

Continue reading

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to September 3, 2024

New York, Aug. 05, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today that on August 2, 2024, its sponsor, Vision Sensing, LLC, deposited $51,016.10 into the Company’s trust account, which is the sum that the Company must pay to extend the date by which the Company must consummate its initial business combination from August 3, 2024, to September 3, 2024 (the “Extension”). This is the fourth of up to six one-month extensions that the Company is authorized to obtain under its amended and restated certificate of incorporation as recently amended on April 30, 2024. The Extension provides the Company with additional time to complete its initial business combination (the “Business Combination”) with Mediforum Co. Ltd., a Korean...

Continue reading

Volaris Reports July 2024 Traffic Results: 90% Load Factor

MEXICO CITY, Aug. 05, 2024 (GLOBE NEWSWIRE) — Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central, and South America, reports its July 2024 preliminary traffic results. In July 2024, Volaris’ ASM capacity decreased by 15.0% year-over-year due to the accelerated Pratt & Whitney engine inspections and the resulting aircraft groundings. Load factor in the month increased by 2.0 pp YoY to 89.8%, as RPMs decreased by 13.0%. Mexican domestic RPMs decreased by 20.0%, while international RPMs increased by 1.0%. Volaris transported 2.7 million passengers during the month. Enrique Beltranena, Volaris’ President and CEO said: “Our strategic fleet mitigation plan is on track and continues to...

Continue reading

Vornado Announces Second Quarter 2024 Financial Results

NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE: VNO) reported today: Quarter Ended June 30, 2024 Financial Results NET INCOME attributable to common shareholders for the quarter ended June 30, 2024 was $35,260,000, or $0.18 per diluted share, compared to $46,377,000, or $0.24 per diluted share, for the prior year’s quarter. FUNDS FROM OPERATIONS (“FFO”) attributable to common shareholders plus assumed conversions (non-GAAP) for the quarter ended June 30, 2024 was $148,944,000, or $0.76 per diluted share, compared to $144,059,000, or $0.74 per diluted share, for the prior year’s quarter. Adjusting for the items that impact period-to-period comparability listed in the table on the following page, FFO attributable to common shareholders plus assumed conversions, as adjusted (non-GAAP)...

Continue reading

J & J Snack Foods Reports Record Fiscal Third Quarter Revenue of $440.0 Million

Gross Margin of 33.6% Leads to Net Earnings of $36.3 Million, and EPS of $1.87 and Adjusted EPS of $1.98 MOUNT LAUREL, N.J., Aug. 05, 2024 (GLOBE NEWSWIRE) — J&J Snack Foods Corp. (NASDAQ: JJSF) (the “Company”) today reported financial results for the third quarter ended June 29, 2024.     Third Quarter Actuals $ vs. LY % vs. LY Net Sales $440.0M $14.2M 3.3% Operating Income $50.1M $1.8M 3.8% Net Earnings $36.3M $1.3M 3.8% Earnings per Diluted Share $1.87 $0.06 3.3%         Adjusted Operating Income $53.1M $2.0M 3.9% Adjusted EBITDA $70.9M $4.2M 6.3% Adjusted Earnings per Diluted Share $1.98 $0.06 3.1% This press release contains non-GAAP financial measures. Please refer to the Non-GAAP Financial Measures section below for reconciliations to the most comparable GAAP measures. Dan Fachner, J&J Snack...

Continue reading

Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update

Top-line data expected in December 2024 after having completed enrollment for Phase 2b trial to treat atopic dermatitis (AD) with ANB032, our BTLA agonist Top-line data accelerated and now anticipated in Q1 2025 for Phase 2b trial to treat rheumatoid arthritis (RA) with rosnilimab, our PD-1 agonist Top-line data now anticipated in Q1 2026 for Phase 2 trial to treat ulcerative colitis (UC) with rosnilimab IND accepted by FDA for ANB033, our anti-CD122 antagonist; Phase 1 trial initiation anticipated in Q4 2024 SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the second quarter ended June 30, 2024 and provided a business update. “We’ve had an exceptional quarter as we...

Continue reading

Mueller Water Products Reports 2024 Third Quarter Results

Increased Net Sales 9.2 percent to $356.7 Million Reported Net Income per Diluted Share of $0.30 Achieved Record Adjusted Net Income per Diluted Share of $0.32 Raises Annual Guidance for Net Sales and Adjusted EBITDA ATLANTA, Aug. 05, 2024 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA) announced financial results for its 2024 third quarter ended June 30, 2024. In the third quarter of 2024, the Company: Delivered net sales of $356.7 million, a 9.2 percent increase as compared with $326.6 million in the prior year quarter Reported operating income of $67.0 million as compared with $35.6 million in the prior year quarter and increased adjusted operating income 77.0 percent to $69.9 million as compared with $39.5 million in the prior year quarter Reported operating margin of 18.8 percent as compared with 10.9 percent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.